EUVIMEDEUVIMED entdecken
Crossref

Possible TLR-mediated immunostimulatory effect of Palbociclib in breast cancer

Ibrahim Bayav, Sevda Sağ, Huriye Ergezgin, Yavuz Dodurga, Ayse Gaye Tomatir

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-025-11282-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Ibrahim Bayav und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Pamukkale University, Kınıklı, Denizli, Turkey. Hauptthemen laut MEDLINE: Piperazines, Pyridines, Breast Neoplasms, Toll-Like Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Palbociclib, which exerts its effect by inhibiting the cell cycle in cancer cells, is a CDK inhibitor used in the treatment of ER+/HER- breast cancer. In this study, we aimed to investigate the effect of Pablosiklib on TLR, which plays an important role in the immune response, in MCF-7 (ER+/HER2-) and MDA-MB-231 (ER-/PR-/HER2-) cell lines. METHODS AND RESULTS: The expression levels of TLR 1-10 genes, cell cycle-related genes (CDK4/6), and genes involved in the apoptotic pathway (Bcl-2, Bax, Cas-3) in MCF-7 and MDA-MB-231 cells treated with palbociclib were evaluated using the real-time PCR (qRT-PCR) method. Additionally, the levels of total retinoblastoma (RB) and phosphorylated retinoblastoma (pRB) proteins were analyzed using the Western blot method. CDK4/6 and pRB expression decreased in MCF-7 and MDA-MB-231 cells treated with palbociclib. Bax and Cas-3 expression increased, while Bcl-2 expression decreased. Changes in TLR expression were also observed. CONCLUSIONS: We believe that palbociclib not only stops the cell cycle and induces apoptosis in breast cancer cells, but also activates the immune response via TLRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperazinesPyridinesBreast NeoplasmsToll-Like ReceptorsHumansFemaleApoptosisCell Line, TumorMCF-7 CellsGene Expression Regulation, NeoplasticCyclin-Dependent Kinase 4Retinoblastoma ProteinCyclin-Dependent Kinase 6Cell ProliferationAntineoplastic Agents

Stichwörter der Autor:innen

Breast cancerPalbociclibToll-like receptors

Substanzen

palbociclibPiperazinesPyridinesToll-Like ReceptorsCyclin-Dependent Kinase 4Retinoblastoma ProteinCyclin-Dependent Kinase 6Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Pamukkale University, Kınıklı, Denizli, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Pamukkale University, Kınıklı, Denizli, Turkey. hergezgin22@posta.pau.edu.tr.

Zitieren

APA

Bayav, I., Sağ, S., Ergezgin, H., Dodurga, Y., & Tomatir, A. G. (2026). Possible TLR-mediated immunostimulatory effect of Palbociclib in breast cancer. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11282-9

Vancouver

Bayav I, Sağ S, Ergezgin H, Dodurga Y, Tomatir AG. Possible TLR-mediated immunostimulatory effect of Palbociclib in breast cancer. Molecular Biology Reports. 2026. doi:10.1007/s11033-025-11282-9

BibTeX
@article{Bayav2026,
  author = {Bayav, Ibrahim and Sağ, Sevda and Ergezgin, Huriye and Dodurga, Yavuz and Tomatir, Ayse Gaye},
  title = {Possible TLR-mediated immunostimulatory effect of Palbociclib in breast cancer},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-025-11282-9}
}
Kostenlos starten →